Why Hire a Rexulti Lawyer?

What Are the Side Effects of Rexulti?

There are many common side effects associated with taking Rexulti. However, in February 2018, a warning listing compulsive gambling and other compulsive behaviors as potential side effects was added to Rexulti’s drug label. Compulsive gambling can lead to significant financial loss, including bankruptcies and home foreclosures. There are also other compulsive behaviors associated with Rexulti, including sexual behavior, eating, and shopping.

How Do I Know If My Compulsive Gambling Is Caused by Rexulti?

The best way to determine this is to look for the challenge, dechallenge, rechallenge pattern.

Challenge: An individual is prescribed Rexulti as part of their medication regimen.

Resultant Experience: The individual experiences compulsive behaviors, namely compulsive gambling, that are atypical of their personality.

Dechallenge: The individual stops taking Rexulti.

Resultant Experience: Compulsive gambling behavior fades or disappears once the individual stops taking Rexulti.

Rechallenge: The individual begins to take Rexulti again.

Resultant Experience: The individual experiences compulsive gambling behaviors again.

Why Should I Hire a GoldenbergLaw Rexulti Lawyer?

GoldenbergLaw has over 30 years of experience in defective drug litigation. Partner Marlene Goldenberg has been appointed to the Plaintiffs’ Steering Committee for the Abilify multidistrict litigation. Abilify, like Rexulti, is a prescription drug Plaintiffs all over the country are alleging caused compulsive behaviors, including compulsive gambling.  Ms. Goldenberg also serves as the litigation’s Discovery Liaison. Our team of Rexulti lawyers has the knowledge, experience, and compassion you want for your Rexulti case. Our law firm has an established reputation in the legal community all over the country because of our outstanding work and commitment to our clients’ well-being.

If you or a loved one has taken Rexulti and experienced compulsive gambling, contact our Rexulti lawyers. Leave the sleepless nights to us.


Talk With Us >

Safety Announcement for Those Taking Rexulti

On February 9, 2018, the FDA approved an update to the Warnings and Precautions for the drug Rexulti regarding compulsive gambling and other compulsive behaviors.  Such side effects are already being litigated nationally with regard to Rexulti’s predecessor drug, Abilify.

Label Change

OptumRX, a nationally regarded pharmacy care services company recently stated:

“Post-marketing case reports suggest that patients can experience intense urges, particularly for gambling, and the inability to control these urges while taking Rexulti. Other compulsive urges, reported less frequently, include sexual urges, shopping, eating or binge eating, and other impulsive or compulsive behaviors.

  • Because patients may not recognize these behaviors as abnormal, it is important for           prescribers to ask patients or their caregivers specifically about the development of new or intense gambling urges, compulsive sexual urges, compulsive shopping, binge or compulsive eating, or other urges while being treated with Rexulti.
  • In some cases, although not all, urges were reported to have stopped when the dose was reduced or the medication was discontinued.
  • Compulsive behaviors may result in harm to the patient and others if not recognized. Consider dose reduction or stopping the medication if a patient develops such urges.”

Side Effects of Rexulti

Rexulti is used as a complementary drug to antidepressants for the treatment of depression and schizophrenia. The FDA warning for Rexulti is similar to the compulsive gambling warnings issued by the FDA for the drug Abilify on May 3, 2016.

Drug companies have an obligation to warn about serious potential side effects of their drugs. The failure of the manufacturer Otsuka to warn of compulsive gambling could have saved some users from losing their life savings, liquidating their 401ks, going into serious debt, or even declaring bankruptcy. Some individuals have been so devastated by their losses that they have even attempted suicide.

Our Involvement

Currently, Partner Marlene Goldenberg of GoldenbergLaw is helping to lead a national litigation involving compulsive gambling and the drug Abilify. The Abilify Multidistrict Litigation is currently progressing in the Northern District of Florida before the Honorable M. Casey Rodgers and revolves around the drug manufacturer’s failure to warn of the serious side effect of compulsive gambling. Rexulti was put on the market in 2015 and is the successor drug to Abilify. Rexulti has similar issues of compulsive gambling, but Otsuka failed to warn about this despite knowing it had a very similar profile to Abilify as a dopamine D2 receptor partial agonist.

Contact Us

Compulsive gambling has devastating effects on people’s lives and dramatically affects their families. If you or a loved one incurred gambling debt of over $30,000 while taking Abilify or Rexulti, you may have a legal claim to help recover your losses. Please contact Marlene Goldenberg at mjgoldenberg@goldenberglaw.com or 612-436-5028.

BREAKING NEWS: Otsuka Adds ‘Compulsive Gambling’ as Possible Side Effect to Rexulti’s Drug Label

In February 2018, Otsuka changed the Rexulti drug label to include compulsive gambling and other compulsive behaviors as potential side effects of taking the antipsychotic. Rexulti (brexpiprazole) is used to treat schizophrenia and as an adjunctive therapy for major depressive disorder. Otsuka now concedes that, “post-marketing case reports suggest that patients can experience intense urges, particularly for gambling, and the inability to control these urges while taking Rexulti.” Otsuka is recommending that patients experiencing compulsive gambling and other compulsive behaviors while taking Rexulti should talk to their medical providers immediately about reducing or discontinuing use.

Rexulti is a successor drug to Abilify, another antipsychotic manufactured by Otsuka. Both drugs are chemically similar and work to control the release of dopamine to improve a patient’s state of mind. In 2016, FDA required that a warning be added to the Abilify label to warn of the compulsive behavior side effect. Lawsuits regarding compulsive gambling as a result of taking Abilify are currently proceeding in a Multi-District Litigation before the Honorable M. Casey Rodgers in the Northern District of Florida. GoldenbergLaw Partner Marlene Goldenberg serves on the Plaintiffs’ Steering Committee as the Discovery Liaison.

GoldenbergLaw is currently investigating claims against Rexulti in which an individual experienced compulsive gambling. Contact GoldenbergLaw today for a free consultation.